Humana (HUM) is a publicly traded Healthcare sector company. As of November 17, 2026, HUM trades at $446.00 with a market cap of $54.05B and a P/E ratio of 36.34. HUM moved -3.31% today. Year to date, HUM is +74.39%; over the trailing twelve months it is +94.52%. Its 52-week range spans $163.11 to $462.70. Analyst consensus is buy with an average price target of $500.90. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HUM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HUM recently traded at $446.00. Market cap is $54.05B. P/E ratio is 36.34. Revenue is $145.68B.
| Metric | Value |
|---|---|
| Price | $446.00 |
| Market Cap | $54.05B |
| P/E Ratio | 36.34 |
| EPS | $10.65 |
| Dividend Yield | 0.89% |
| 52-Week High | $462.70 |
| 52-Week Low | $163.11 |
| Volume | 4.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $145.68B |
| Net Income | $1.29B |
| Gross Margin | 0.00% |
20 analysts cover HUM: 0 strong buy, 14 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $500.90.